Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease;Valor pronóstico de la troponina T de alta sensibilidad tras intervención coronaria percutánea en pacientes con enfermedad coronaria estable

Revista Espanola de Cardiologia

Volumn 69, Issue 8, 2016, Pages 746-753

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   Cassese, Salvatore ^a   Mayer, Katharina ^a   Lohaus, Raphaela ^a   Lahmann, Anna L ^a   Fusaro, Massimiliano ^a   Laugwitz, Karl Ludwig ^b,c   Schunkert, Heribert ^a,c   Kastrati, Adnan ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Coronary artery disease; Percutaneous coronary intervention; Prognosis; Stable angina; Troponin

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER;

ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CORONARY BIFURCATION LESION; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; AGED; BLOOD; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY;

AGED; BIOMARKERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; TROPONIN T;

EID: 84971633014     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2016.02.023     Document Type: Article

References (25)

1. Lansky, A.J., Stone, G.W., Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 3 (2010), 602–610.
2. Clerico, A., Giannoni, A., Prontera, C., Giovannini, S., High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv Clin Chem. 49 (2009), 1–30.
3. Apple, F.S., Collinson, P.O., Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 58 (2012), 54–61.
4. Jaffe, A.S., Ordonez-Llanos, J., Troponina cardiaca ultrasensible: de la teoría a la práctica clínica. Rev Esp Cardiol. 66 (2013), 687–691.
5. Morrow, D.A., Clinical application of sensitive troponin assays. N Engl J Med. 361 (2009), 913–915.
6. Diamond, G.A., Kaul, S., How would the Reverend Bayes interpret high-sensitivity troponin?. Circulation. 121 (2010), 1172–1175.
7. Grines, C.L., Dixon, S., A nail in the coffin of troponin measurements after percutaneous coronary intervention. J Am Coll Cardiol. 57 (2011), 662–663.
8. Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 60 (2012), 1581–1598.
9. Patel, V.G., Brayton, K.M., Tamayo, A., Mogabgab, O., Michael, T.T., Lo, N., et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 6 (2013), 128–136.
10. Resnic, F.S., Wainstein, M., Lee, M.K., Behrendt, D., Wainstein, R.V., Ohno-Machado, L., et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 145 (2003), 42–46.
11. Bhatt, D.L., Lincoff, A.M., Gibson, C.M., Stone, G.W., McNulty, S., Montalescot, G., et al. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 361 (2009), 2330–2341.
12. Yokoyama, Y., Chaitman, B.R., Hardison, R.M., Guo, P., Krone, R., Stocke, K., et al. Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. Am J Cardiol. 86 (2000), 819–824.
13. Feldman, D.N., Kim, L., Rene, A.G., Minutello, R.M., Bergman, G., Wong, S.C., Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 77 (2011), 1020–1030.
14. Pervaiz, M.H., Sood, P., Sudhir, K., Hermiller, J.B., Hou, L., Hattori, K., et al. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Circ Cardiovasc Interv. 5 (2012), 150–156.
15. Zimarino, M., Cicchitti, V., Genovesi, E., Rotondo, D., De Caterina, R., Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance?. Atherosclerosis. 221 (2012), 297–302.
16. Selvanayagam, J.B., Porto, I., Channon, K., Petersen, S.E., Francis, J.M., Neubauer, S., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 111 (2005), 1027–1032.
17. Lim, C.C., Van Gaal, W.J., Testa, L., Cuculi, F., Arnold, J.R., Karamitsos, T., et al. With the “universal definition”, measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol. 57 (2011), 653–661.
18. Ndrepepa, G., Mehilli, J., Schulz, S., Iijima, R., Keta, D., Byrne, R.A., et al. Patterns of presentation and outcomes of patients with acute coronary syndromes. Cardiology. 113 (2009), 198–206.
19. Gravning, J., Ueland, T., Morkrid, L., Endresen, K., Aaberge, L., Kjekshus, J., Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris. Scand Cardiovasc J. 42 (2008), 214–221.
20. Miller, W.L., Garratt, K.N., Burritt, M.F., Lennon, R.J., Reeder, G.S., Jaffe, A.S., Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 27 (2006), 1061–1069.
21. White, H.D., The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga. Circ Cardiovasc Interv. 5 (2012), 142–145.
22. Ricciardi, M.J., Davidson, C.J., Gubernikoff, G., Beohar, N., Eckman, L.J., Parker, M.A., et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J. 145 (2003), 522–528.
23. Ndrepepa, G., Braun, S., Mehilli, J., Birkmeier, K.A., Byrne, R.A., Ott, I., et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J. 161 (2011), 68–75.
24. Ndrepepa, G., Braun, S., Schulz, S., Mehilli, J., Schomig, A., Kastrati, A., High-sensitivity troponin T level and angiographic severity of coronary artery disease. Am J Cardiol. 108 (2011), 639–643.
25. Loeb, H.S., Liu, J.C., Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention. Clin Cardiol. 33 (2010), E40–E44.